Shalby Hospitals IPO: Here’s All You Need To Know
Ahmedabad-based Shalby Hospitals will launch its initial public offering today. On offer are 10 lakh shares being sold by promoter Dr Vikram Shah and up to 1.95 crore fresh shares worth Rs 480 crore to raise funds for the business.
- Issue period: Dec. 5 – 7
- Price band: Rs 245 - 248 (implies market capitalisation of Rs 2,680 crore at the upper band)
Eight Things You Need To Know About Shalby
1. Shalby has 11 multi-specialty hospitals with a total 2012 beds and an operational bed count of 841 beds, according to brokerage reports quoting the draft red herring prospectus. The company also provides outpatient services through 47 outpatient clinics and has 10 shared surgery centres within third party hospitals called Shalby Arthroplasty Centre of Excellence. Six outpatient clinics and 1 SACE are in Africa, and two SACE in UAE.
2. It is the market leader in the procedure of joint replacement surgeries with a 15 percent market share of all such surgeries conducted by private corporate hospitals in India in 2016, according to the F&S Report.
3. But the recent National Pharmaceuticals Pricing Authority order fixing a ceiling on the price that can be charged on orthopaedic knee implants could impact Shalby's earnings negatively, said a report by Axis Capital.
4. It operates via a combination of several models ranging from the own and operate model to an asset light one that involved management of hospitals on a revenue sharing basis. Future plans include expanding presence in western and central India.
5. Shalby's revenue increased from Rs 259 crore in FY14 to Rs 325 crore in FY17. Revenue in the first quarter of FY18 was Rs 89 crore. The profit margin increased from 24 percent levels in FY15 to 28.9 percent in Q1 FY18. Profit almost doubled between FY14 and FY17.
6. But the shares are aggressively priced, valuing the company at an EV/EBITDA of 28x on FY18 earnings. That puts it much above peers such as Apollo Hospitals (23x), Fortis Healthcare (20x), Narayana Health (27x) and HCG (23x).
7. The funds raised in the IPO will be used for debt repayment (Rs 300 crore) and expansion of existing hospitals.
8. The company raised more than Rs 150 crore from 11 anchor investors including Goldman Sachs, Citigroup, Reliance Nippon Life Insurance Company, Nomura and SBI Life Insurance Company.
Watch the full interview with the Shalby Hospitals management.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.
